Processa Pharmaceuticals, Inc. (PCSA) Stock Forecast
PCSA analyst forecast
as of October 18, 2026- Analyst consensus
- —
- Price target
- $25.00 average of analyst targets
- Upside to target
- +1,379.3% from the latest close
- Next earnings
- November 5, 2026
- 52-week range
- $1.35 – $9.72
PCSA price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
PCSA earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Next fiscal year (2026) | −$3.75 | −$3.75 | −$3.75 | −$10.75 | +65.1% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
PCSA revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Next fiscal year (2026) | $0 | $0 | $0 | 0.0% | 1 |
PCSA EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
PCSA EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Next fiscal year (2026) | $0.00 | −$5.00 | −$5.00 | −$5.00 | −$3.75 | — | 1 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
PCSA earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; PCSA beat in 7 of 11.
What analysts expect from PCSA
The average price target is $25.00, 1,379.3% above the latest close of $1.69. For 2026 the average estimate is −$3.75 per share. Processa Pharmaceuticals beat the EPS estimate in 7 of the last 11 quarters.
Related: PCSA income statement, PCSA key metrics, PCSA chart. See the PCSA stock overview for the latest quote and news.
PCSA forecast FAQ
What is Processa Pharmaceuticals's price target?
The average analyst price target for Processa Pharmaceuticals is $25.00, 1,379.3% above the latest close of $1.69.
When does Processa Pharmaceuticals report earnings?
Processa Pharmaceuticals is expected to report results for the quarter ending September 30, 2026 on November 5, 2026.
Does Processa Pharmaceuticals usually beat earnings estimates?
Processa Pharmaceuticals reported EPS at or above the analyst estimate in 7 of the last 11 quarters.